IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Phase 2
Recruiting
- Conditions
- High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in PregnancyLupus Anticoagulant Disorder
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- David Ware Branch
- Target Recruit Count
- 55
- Registration Number
- NCT03152058
- Locations
- 🇺🇸
Hospital for Special Surgery, New York, New York, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
🇨🇦TRIO Advancing Reproductive Care, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath